Abstract

Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Highlights

  • NACI first recommended universal varicella vaccination in 1999(1) and published updated guidance in 2002 and 2004(2),(3), as well as in the varicella chapter of the Canadian Immunization Guide, 7th Edition, 2006.(4) More recent epidemiology has been published regarding the effect of single-dose childhood varicella vaccination programs in the United States

  • For susceptible healthy individuals 13 years and older, vaccination with two doses administered four to six weeks apart is recommended.[3],(7)

  • Varicella vaccine was licensed in the U.S in 1995, with a single dose recommended for susceptible children aged 12 months to 12 years, and two doses for susceptible adolescents and adults

Read more

Summary

Relevé des maladies transmissibles au Canada

Recommandations relatives à l’administration de deux doses du vaccin contre la varicelle. Les recommandations d’utilisation et les autres renseignements qui figurent dans le présent document peuvent différer du contenu des monographies de produit établies par les fabricants des vaccins au Canada. Desai (Centre for Immunization and Respiratory Infectious Diseases), LCol (Dr.) James Anderson (Department of National Defence), Dr Ezzat Farzad (First National and Inuit Health Branch - Office of Community Medicine), Dr J. FarhangMehr (Centre de l’immunisation et des maladies respiratoires infectieuses), Dre S. Desai (Centre de l’immunisation et des maladies respiratoires infectieuses), Lcol (Dr) James Anderson (ministère de la Défense nationale), Dre Ezzat Farzad (Direction générale de la santé des Premières nations et des Inuits ‒ Bureau de la médecine communautaire), Dr J. Elliot (Centre de l’immunisation et des maladies respiratoires infectieuses), Dr P. Pless (Centre de l’immunisation et des maladies respiratoires infectieuses)

Introduction
Canadian Varicella Epidemiology and Immunization Program Status
United States Varicella Epidemiology and Immunization Program Status
Background
At preschool
Antibody levels
Shift of varicella disease to older ages
Réduire les éclosions
Survenue de la varicelle à un âge plus avancé
Minimum recommended interval between the doses*
Intervalle minimal recommandé entre les doses*
Level of evidence based on research design
Niveaux de preuve fondés sur la méthodologie de la recherche
Findings
Assez bonne
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call